HK1029919A1 - Method for preventing the misuse of a transdermal therapeutic system - Google Patents

Method for preventing the misuse of a transdermal therapeutic system

Info

Publication number
HK1029919A1
HK1029919A1 HK01100389A HK01100389A HK1029919A1 HK 1029919 A1 HK1029919 A1 HK 1029919A1 HK 01100389 A HK01100389 A HK 01100389A HK 01100389 A HK01100389 A HK 01100389A HK 1029919 A1 HK1029919 A1 HK 1029919A1
Authority
HK
Hong Kong
Prior art keywords
misuse
therapeutic system
transdermal therapeutic
preventing
unauthorised
Prior art date
Application number
HK01100389A
Other languages
English (en)
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HK1029919A1 publication Critical patent/HK1029919A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Radiation-Therapy Devices (AREA)
HK01100389A 1997-10-01 2001-01-15 Method for preventing the misuse of a transdermal therapeutic system HK1029919A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (de) 1997-10-01 1997-10-01 Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
PCT/EP1998/005955 WO1999016428A1 (de) 1997-10-01 1998-09-18 Verfahren zur vermeidung des missbrauchs eines transdermalen therapeutischen systems

Publications (1)

Publication Number Publication Date
HK1029919A1 true HK1029919A1 (en) 2001-04-20

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100389A HK1029919A1 (en) 1997-10-01 2001-01-15 Method for preventing the misuse of a transdermal therapeutic system

Country Status (23)

Country Link
EP (1) EP1019032B1 (da)
JP (2) JP4755338B2 (da)
KR (1) KR100552102B1 (da)
AT (1) ATE228356T1 (da)
AU (1) AU759609B2 (da)
CA (1) CA2305432C (da)
DE (2) DE19743484C1 (da)
DK (1) DK1019032T3 (da)
ES (1) ES2188021T3 (da)
HK (1) HK1029919A1 (da)
HU (1) HU226644B1 (da)
ID (1) ID24333A (da)
IL (1) IL134479A (da)
MY (1) MY116425A (da)
NO (2) NO319163B1 (da)
NZ (1) NZ503643A (da)
PL (1) PL193066B1 (da)
PT (1) PT1019032E (da)
SK (1) SK3332000A3 (da)
TR (1) TR200000461T2 (da)
TW (1) TW431894B (da)
WO (1) WO1999016428A1 (da)
ZA (1) ZA988904B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
JP7329857B2 (ja) * 2018-10-17 2023-08-21 日榮新化株式会社 粘着シート及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE19743484C1 (de) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems

Also Published As

Publication number Publication date
PL339736A1 (en) 2001-01-02
NO20001691L (no) 2000-03-31
DK1019032T3 (da) 2003-03-10
KR20010030886A (ko) 2001-04-16
CA2305432A1 (en) 1999-04-08
HU226644B1 (en) 2009-05-28
ES2188021T3 (es) 2003-06-16
HUP0003476A3 (en) 2001-04-28
NZ503643A (en) 2003-05-30
NO319163B1 (no) 2005-06-27
HUP0003476A2 (hu) 2001-02-28
AU759609B2 (en) 2003-04-17
MY116425A (en) 2004-01-31
NO20001691D0 (no) 2000-03-31
KR100552102B1 (ko) 2006-02-13
CA2305432C (en) 2007-04-03
JP2001517695A (ja) 2001-10-09
IL134479A0 (en) 2001-04-30
JP4755338B2 (ja) 2011-08-24
TR200000461T2 (tr) 2000-09-21
DE19743484C1 (de) 1999-01-28
EP1019032A1 (de) 2000-07-19
PT1019032E (pt) 2003-04-30
ID24333A (id) 2000-07-13
DE59806468D1 (de) 2003-01-09
NO20001492D0 (no) 2000-03-22
AU9626598A (en) 1999-04-23
WO1999016428A1 (de) 1999-04-08
NO20001492L (no) 2000-03-22
IL134479A (en) 2005-07-25
SK3332000A3 (en) 2000-11-07
PL193066B1 (pl) 2007-01-31
ATE228356T1 (de) 2002-12-15
TW431894B (en) 2001-05-01
JP2009035561A (ja) 2009-02-19
ZA988904B (en) 1999-04-12
EP1019032B1 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
IL149890A0 (en) Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated
BG101131A (en) 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons
AU6733298A (en) Method for user identity protection
EP1028715A4 (en) FORMULATION FOR NASAL SUPPORT AND METHOD OF USE THEREOF
ZA99104B (en) Method for administering ASPB28-human insulin.
GB2352395A (en) Paroxetine methanesulfonate
IL114294A0 (en) Sterol derivatives
AU8695698A (en) Pharmacologic drug combination in vagal-induced asystole
AU8736798A (en) Use of cholinesterase inhibitors for treating attention deficit disorders
MXPA03011825A (es) Combinacion de ingrediente activo para tratar una dependencia de sustancias aditivas o narcoticas utilizando medicamentos.
AU4428597A (en) Iontophoretic drug delivery system, including method for activating same
AU8239298A (en) Nucleotide-comprising composition
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
PL323145A1 (en) Transcutaneous therapeutic system (tts) for administering testosterone
HK1029919A1 (en) Method for preventing the misuse of a transdermal therapeutic system
HK1025558A1 (en) Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
AU9294698A (en) Methods and compositions for enhanced wound healing
AP2000001746A0 (en) Anti- first-pass effect compounds.
AU5434899A (en) Cancer treatment
IL147500A0 (en) Method for delivery of therapeutic agents using a solution of dextrin
AU1143899A (en) Transdermal delivery of 3,4-diarylchromans
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
UA36385A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120918